CAMP (cathelicidin) transcript levels and protein secretion were also measured.<h4>Results</h4>Pre-treatment of End1, Ect1 and Vk2 epithelial monolayers with VitD reduced HIV-infection of the CD4+ T cells in the basal chamber by 50%, 53%, and 31%, respectively. The gene discussed is CAMP; the disease is HIV infectious disease.